Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Christina G Rivera"'
Autor:
Maria Lourdes Gonzalez Suarez, Kristin C Mara, Christina G Rivera, Supavit Chesdachai, Evan Draper, Raymund R Razonable
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0303896 (2024)
Background and aimRenal dysfunction is associated with poor outcomes in patients with coronavirus disease 2019 (COVID-19). In an effort to improve outcomes, intravenous remdesivir has been broadly used for the treatment of COVID-19 even in patients w
Externí odkaz:
https://doaj.org/article/93f5ec8fe68a4e5d9066424c6b0dc5d7
Autor:
Nathan W Cummins, Jason Baker, Rana Chakraborty, Patrick G Dean, Enrique Garcia-Rivera, Ashton Krogman, Shaji Kumar, Yury V Kuzmichev, Gregory M Laird, Alan Landay, Mathias Lichterfeld, Maryam Mahmood, Jeffrey Martinson, Mark Maynes, Sekar Natesampillai, Vincent Rajkumar, Yelizaveta Rassadkina, Kristen D. Ritter, Christina G Rivera, Stacey A Rizza, Krupa Subramanian, Aaron J Tande, Elizabeth R Wonderlich, Jennifer A Whitaker, John Zeuli, Andrew D Badley
Publikováno v:
EClinicalMedicine, Vol 42, Iss , Pp 101225- (2021)
Background: Achieving a functional or sterilizing cure for HIV will require identification of therapeutic interventions that reduce HIV reservoir size in infected individuals. Proteasome inhibitors, such as ixazomib, impact multiple aspects of HIV bi
Externí odkaz:
https://doaj.org/article/9bcbc1806c0c4535bde930e29c873a95
Autor:
Ming M. Zhang, Ryan W. Stevens, Jennifer L. Adema, Kristin C. Mara, Audrey N. Schuetz, Aaron J. Tande, Christina G. Rivera
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 9, Pp 2295-2305 (2023)
Abstract Introduction Daptomycin doses 8–12 mg/kg are recommended for susceptible dose-dependent Enterococcus species. However, data remain limited on safety outcomes of such dosing, compared to standard 4–6 mg/kg dosing. Methods In this retrospe
Externí odkaz:
https://doaj.org/article/1e1c5ad6232247cea29c5addcb8bb6c9
Autor:
Amy L. Van Abel, Lindsey M. Childs-Kean, Kelsey L. Jensen, Ryan P. Mynatt, Keenan L. Ryan, Christina G. Rivera
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Outpatient parenteral antimicrobial therapy (OPAT) has been widely used in clinical practice for many decades because of its associated cost savings, reductions in inpatient hospital days, and decreases in hospital-associated infections. Despite this
Externí odkaz:
https://doaj.org/article/59475e96347344639e3f018d1311bf59
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Antimicrobial therapy is an essential practice within medicine. Over the last 4 years, complex outpatient antimicrobial therapy (COpAT) with oral antimicrobials has become a rapidly developing area of practice and is non-inferior to outpatient parent
Externí odkaz:
https://doaj.org/article/5945e217b32d48bf8872f78228797861
Autor:
Tanner M. Johnson, Leah C. Whitman Webster, Meera Mehta, Jessica E. Johnson, Nicolás Cortés-Penfield, Christina G. Rivera
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Intravenous push (IVP) antimicrobial administration refers to rapid bolus infusion of medication. This drug delivery method offers improved patient convenience, superior patient and nursing satisfaction, and cost savings when used in outpatient paren
Externí odkaz:
https://doaj.org/article/d245d5068ed44e18b7db8554affc8112
Autor:
Lauren M. Dolly, Christina G. Rivera, Kelsey L. Jensen, Kristin C. Mara, Diana J. Schreier, Abinash Virk, Kellie N. Arensman Hannan
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Background: Data are controversial regarding nephrotoxicity risk with vancomycin plus piperacillin–tazobactam (VPT) compared to vancomycin alone or in combination with other beta-lactams (BLs) in acute care use. Furthermore, data are lacking on the
Externí odkaz:
https://doaj.org/article/f1ae5f7a6838453ba6deccb8b8baaa28
Autor:
Tanner M. Johnson, Thomas F. Byrd, Wendi K. Drummond, Lindsey M. Childs-Kean, Monica V. Mahoney, Jeffrey C. Pearson, Christina G. Rivera
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 2, Pp 343-365 (2023)
Abstract Nontuberculous mycobacteria (NTM) are a group of atypical bacteria that may cause a spectrum of clinical manifestations, including pulmonary, musculoskeletal, skin and soft tissue, and cardiac infections. Antimycobacterial medication regimen
Externí odkaz:
https://doaj.org/article/6cabe6ba32f64f7396292db80651ded3
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 30, Iss , Pp 100346- (2023)
Purpose: Infections caused by non-tuberculous mycobacterium (NTM) are increasing, less well-known by health care clinicians, and usually require long term treatment with multiple antimicrobials. There is no existing evidence on clinical pharmacists
Externí odkaz:
https://doaj.org/article/670212fb4e1442218ddb6b360a0d7807
Autor:
Jennifer L. Adema, Aileen Ahiskali, Madiha Fida, Krutika Mediwala Hornback, Ryan W. Stevens, Christina G. Rivera
Publikováno v:
Pathogens, Vol 12, Iss 5, p 703 (2023)
Infective endocarditis (IE) is a rare but increasingly prevalent disease with high morbidity and mortality, requiring antimicrobials and at times surgical intervention. Through the decades of healthcare professionals’ experience with managing IE, c
Externí odkaz:
https://doaj.org/article/49f4259c1a7c4a0f8dd2f76c9bd7cab8